Investor insights
Sectors invested in
Funding rounds participated in
$21M sweet spot round size
Most of their 19 investments are in rounds between $8.5M and $38M
Investor type
Basic info
Industry
Sectors
Date founded
2006
Investments made
Cardeas Pharma Corp. raised $38M on April 10, 2015
Investors: H.I.G. BioVentures, Washington Research Foundation, Delphi Ventures, Avalon Venture and Devon Park Bioventures
Undisclosed raised $45M on May 16, 2014
Investors: TVM Life Science Management Inc, Sky Ventures, MPM Capital, Prism Venture Partners, Inbio Ventures, Intersouth Partners and Devon Park Bioventures
ZS Pharma, Inc. raised $55M on March 5, 2014
Investors: RiverVest Venture Partners, Adage Capital Management, Sofinnova Ventures, Russia technology fund, Salem Partners LLC, Novo Holdings, RA Capital Management, L.P., Alta Partners and Devon Park Bioventures
Undisclosed raised $7M on September 27, 2013
Investors: Horizon Technology Finance, Pitango Venture Capital and Devon Park Bioventures
Undisclosed raised $21M on September 27, 2013
Investors: Pitango Venture Capital and Devon Park Bioventures
MicuRx Pharmaceuticals, Inc. raised $25M on August 22, 2013
Investors: BioVeda China Fund and Devon Park Bioventures
ZS Pharma, Inc. raised $46M on October 23, 2012
Investors: RiverVest Venture Partners, Partisan Management Group Inc, Salem Partners LLC, Alta Partners and Devon Park Bioventures
Cardeas Pharma Corp. raised $8.5M on June 7, 2012
Investors: Avalon Venture and Devon Park Bioventures
Cara Therapeutics raised $4.8M on May 21, 2012
Investors: Alta Partners, CT Innovation, Ascent Biomedical Ventures, MVM Partners and Devon Park Bioventures
Undisclosed raised $7M on February 22, 2012
Investors: Devon Park Bioventures